Vitura Health Limited (ASX:VIT – Get Free Report) insider Robert Iervasi purchased 179,200 shares of the stock in a transaction dated Wednesday, September 4th. The stock was acquired at an average price of A$0.08 ($0.06) per share, for a total transaction of A$15,052.80 ($10,035.20).
Vitura Health Stock Performance
Vitura Health Company Profile
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia and Asia. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for medicinal cannabis; CDA Clinics, which provides medicinal cannabis consultations and prescription services; and Cannadoc, a medicinal cannabis clinic that offers telehealth consultations.
Featured Articles
- Five stocks we like better than Vitura Health
- Stock Market Upgrades: What Are They?
- Matador Resources Insiders Keep Buying Its Stock, Should You?
- About the Markup Calculator
- Oracle Can Turn the Magnificent 7 Into 8: Here’s Why
- Election Stocks: How Elections Affect the Stock Market
- Palantir Stock Is Up 14% on S&P 500 News: Is It Time to Buy?
Receive News & Ratings for Vitura Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitura Health and related companies with MarketBeat.com's FREE daily email newsletter.